title: Design and kinetic analysis of hammerhead ribozyme and DNAzyme that specifically cleave TEL-AML1 chimeric mRNA.
abstract: In order to develop the oligonucleotides to abolish an expression of TEL-AML1 chimeric RNA, which is a genetic aberration that causes the acute lymphoblastic leukemia (ALL), hammerhead ribozymes and deoxyoligoribozymes that can specifically cleave TEL-AML1 fusion RNA were designed. Constructs of the deoxyribozyme with an asymmetric substrate binding arm (Dz26) and the hammerhead ribozyme with a 4nt-bulged substrate binding arm in the stem III (buRz28) were able to cleave TEL-AML1 chimeric RNA specifically at sites close to the junction in vitro, without cleaving the normal TEL and AML1 RNA. Single-turnover kinetic analysis under enzyme-excess condition revealed that the buRz28 is superior to the Dz26 in terms of substrate binding and RNA-cleavage. In conjunction with current progress in a gene-delivery technology, the designed oligonucleotides that specifically cleave the TEL-AML1 chimeric mRNA are hoped to be applicable for the treatment of ALL in vivo.
authors.affiliation: Department of Bioscience and Biotechnology, Konkuk University, 1-Hwayang-dong, Gwangjin-gu, Seoul 143-701, Republic of Korea.
authors.forename: Woo-Hyung
authors.initials: WH
authors.lastname: Choi
authors.forename: Bo-Ra
authors.initials: BR
authors.lastname: Choi
authors.forename: Jae Hyun
authors.initials: JH
authors.lastname: Kim
authors.forename: Woon-Seok
authors.initials: WS
authors.lastname: Yeo
authors.forename: Sangtaek
authors.initials: S
authors.lastname: Oh
authors.forename: Dong-Eun
authors.initials: DE
authors.lastname: Kim
mesh_terms: D002384:Catalysis; D045744:Cell Line, Tumor; D050676:Core Binding Factor Alpha 2 Subunit / Q000037:antagonists & inhibitors* / Q000235:genetics; D021881:DNA, Catalytic / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D018014:Gene Transfer Techniques; D006801:Humans; D007700:Kinetics; D009841:Oligonucleotides / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D015514:Oncogene Proteins, Fusion / Q000037:antagonists & inhibitors* / Q000235:genetics; D016337:RNA, Catalytic / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000737:chemistry / Q000378:metabolism*; D000097764:ETS Translocation Variant 6 Protein
chemical_list: D050676:Core Binding Factor Alpha 2 Subunit; D021881:DNA, Catalytic; D009841:Oligonucleotides; D015514:Oncogene Proteins, Fusion; D016337:RNA, Catalytic; D012333:RNA, Messenger; C102421:TEL-AML1 fusion protein; D000097764:ETS Translocation Variant 6 Protein; C427204:hammerhead ribozyme